The findings in MSH6 and PMS2 are of particular clinical importance, as these data are extremely limited in the literature until recently, yet clinicians counsel about a general increased risk for ovarian cancer with PVs in Lynch syndrome genes. Here, MSH6 is linked to ovarian cancer.